Tenax Therapeutics Inc. (TENX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
1. 36
-0.15
-9.9338%
$
49.6M Market Cap
- P/E Ratio
- Div Yield
1.77M Volume
-7.42 Eps
$ 1.51
Previous Close 
Want to track TENX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tenax Therapeutics Inc. (TENX) Statistics
Valuation metrics
Market Cap 49.6M
Enterprise value -68.37M
Trailing P/E (ttm) -1.26
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) -
Price/Book (mrq) 0.84
Enterprise Value/Revenue -
Enterprise Value/EBITDA 1.04
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.34M
Average volume (90 days) 3.94M
Price summary
52-Week low 1.31
52-Week high 19.4
Beta -
50-Day moving average 1.95
200-Day moving average 11.84
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:80
Last split Date 3 Jan 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.53%
Return on equity -0.62%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.32
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 15.07%
Book value per share (mrq) 2.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
